Диссертация (1139759), страница 20
Текст из файла (страница 20)
Reson. Imaging. – 2001. –V.12(4). – P. 221-230.46.Demir O.I Contribution of diffusion-weighted MRI to the differentialdiagnosis of hepatic masses / O.I. Demir, F. Obuz, O. Sağol [et al] // Diagn.Interv. Radiol. – 2007. – V. 13(2). – P. 81-86.47.Ding Y. Preoperative evaluation of colorectal liver metastases: comparisonof gadopentetate dimeglumine and gadoxetic-acid-enhanced 1.5-T MRI / Y. Ding,S.X. Rao, T. Meng [et al] // Clin.
Imaging. – 2014. – V. 38(3). – P. 273-278.48.Dokmak S. A single-center surgical experience of 122 patients with singleand multiple hepatocellular adenomas / S. Dokmak, V. Paradis, V. Vilgrain [et al]// Gastroenterology. – 2009. – V. 137 (5). – P. 1698–1705.49.Eiber M. Detection and classification of focal liver lesions in patients withcolorectal cancer: retrospective comparison of diffusion-weighted MR imaging andmulti-slice CT/ M.
Eiber, A.A. Fingerle, M. Brügel [et al] // Eur. J. Radiol. –2012. – V. 81(4). – P. 683-91.50.Elsayes K.M. 2017 Version of LI-RADS for CT and MR Imaging: AnUpdate / K.M. Elsayes, J.C. Hooker, M.M. Agrons [et al] // Radiographics. – 2017.– V. 37 (7). – P.
1994-2017.51.Errante Y. Progressive increase of T1 signal intensity of the dentate nucleuson unenhancedmagnetic resonance images is associated with cumulative doses ofintravenouslyadministered gadodiamide in patients with normal renal function,suggesting dechelation / Y. Errante, V. Cirimele, C.A. Mallio [et al] // InvestRadiol. – 2014. – V.49 (10). – P. 685-690.52.European Association For The Study Of The Liver; European OrganizationFor Research And Treatment Of Cancer. EASL-EORTC clinical practiceguidelines: management of hepatocellular carcinoma // J. Hepatol. – 2012. – V.56(4).
– P. 908-943.12853.Fukusato T. Preserved or enhanced OATP1B3 expression in hepatocellularadenoma subtypes with nuclear accumulation of β-catenin / T. Fukusato, Y.Soejima, F. Kondo [et al] // Hepatol. Res. – 2015. – V. 45 (10). – P. 32-42.54.Girometti R. Accuracy of visual analysis vs. apparent diffusion coefficientquantification in differentiating solid benign and malignant focal liver lesions withdiffusion-weighted imaging / R. Girometti, M. Del Pin, S. Pullini [et al] // Radiol.Med. – 2013. – V.118(3).
– P. 343-355.55.Golfieri R. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm)HCC in cirrhosis / R. Golfieri, M. Renzulli, V. Lucidi [et al] // Eur. Radiol. – 2011.– V. 21 (6). – P. 1233-1242.56.Golfieri R. Which is the best MRI marker of malignancy for atypicalcirrhotic nodules: hypointensity in hepatobiliary phase alone or combined withother features? Classification after Gd-EOB-DTPA administration / R. Golfieri, L.Grazioli, E. Orlando [et al] // J.
Magn. Reson. Imaging. – 2012. – V. 36(3). – P.648-657.57.Goodwin M.D. Diagnostic challenges and pitfalls in MR imaging withhepatocyte-specific contrast agents / M.D. Goodwin, J.E. Dobson, C.B. Sirlin [etal] // Radiographics. – 2011. – V. 31 (6). – P.1547-1568.58.Goshima S. Diffusion-weighted imaging of the liver: optimizing b value forthe detection and characterization of benign and malignant hepatic lesions / S.Goshima, M.
Kanematsu, H. Kondo [et al] // J. Magn. Reson. Imaging. – 2008. –V. 28(3). – P. 691-697.59.Gourtsoyianni S. Respiratory gated diffusion-weighted imaging of the liver:value of apparent diffusion coefficient measurements in the differentiation betweenmost commonly encountered benign and malignant focal liver lesions / S.Gourtsoyianni, N.
Papanikolaou, S. Yarmenitis [et al] // Eur. Radiol. – 2008. – V.18(3). – P. 486-92.12960.Grieser C. Gadoxetic acid enhanced MRI for differentiation of FNH andHCA: a single centre experience / C. Grieser, I.G. Steffen, I.B. Kramme [et al] //Eur. Radiol. – 2014. – V. 24 (6). – P. 1339-1348.61.Gulani V. Effect of Contrast Media on Single Shot EPI: Implications forAbdominal Diffusion Imaging / V.
Gulani, J.M. Willatt, M. Blaimer [et al] // J.Magn. Reson. Imaging. – 2009. – V. 30(5). – P.1203–1208.62.Ha S. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase inthe evaluation of hepatic metastasis from breast cancer: is the "target sign" acommon finding? / S. Ha, C.H. Lee, B.H. Kim [et al] // Magn. Reson. Imaging. –2012. – V. 30(8).
– P. 1083-1090.63.Haimerl M. Assessment of clinical signs of liver cirrhosis using T1 mappingon Gd-EOB-DTPA-enhanced 3T MRI / M. Haimerl, N. Verloh, F. Zeman [et al] //PLoS One. – 2013. – V. 8(12):e85658.64.Han N.Y. Chemotherapy-induced focal hepatopathy in patients withgastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MRimaging with clinical-pathologic correlation / N.Y.
Han, B.J. Park, D.J. Sung [etal] // Radiology. – 2014. – V. 271(2). – P. 416-25.65.Holzapfel K. Characterization of small (≤10 mm) focal liver lesions: valueof respiratory-triggered echo-planar diffusion-weighted MR imaging / K.Holzapfel, M. Bruegel, M. Eiber [et al] // Eur. J. Radiol. – 2010. – V.76(1). – P.8995.66.Holzapfel K. Comparison of diffusion-weighted MR imaging andmultidetector-row CT in the detection of liver metastases in patients operated forpancreatic cancer / K.
Holzapfel, C. Reiser-Erkan, A.A. Fingerle [et al] // Abdom.Imaging. –2011. – V. 36(2). – P.179-184.67.Hope T.A. Hepatobiliary agents and their role in LI-RADS / T.A. Hope, K.J.Fowler, C.B. Sirlin [et al] // Abdom. Imaging. – 2015. – V.40 (3). – P.613-625.68.Hwang J. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronicliver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic13064-multirow detector CT / J. Hwang, S.H. Kim, M.W.
Lee [et al] // Br. J. Radiol. –2012. – V. 85 (1015). – P. 314-322.69.Hwang J. Gadoxetic acid-enhanced MRI versus multiphase multidetectorrow computed tomography for evaluating the viable tumor of hepatocellularcarcinomas treated with image-guided tumor therapy / J. Hwang, S.H. Kim, Y.S.Kim [et al] // J. Magn. Reson. Imaging. – 2010. – V.32(3). – P. 629-638.70.Ishimaru H. Local recurrence after chemoembolization of hepatocellularcarcinoma: uptake of gadoxetic acid as a new prognostic factor / H. Ishimaru, K.Nakashima, T. Sakugawa [et al] // Am.
J. Roentgenol. – 2014. – V. 202 (4). – P.744-751.71.Jenkinson M.D. Cellularity and apparent diffusion coefficient inoligodendroglial tumours characterized by genotype / M.D. Jenkinson, D.G. duPlessis, T.S. Smith [et al] // J. Neurooncol. – 2010. – V.96(3). – P. 385-392.72.JeongH.T.Gadoxetate disodium-enhancedMRI of mass-formingintrahepatic cholangiocarcinomas: imaging-histologic correlation / H.T.
Jeong,M.J. Kim , Y.E. Chung [et al] // Am. J. Roentgenol. – 2013. – V.201(4). – P.603611.73.Kanda T. High signal intensity in the dentate nucleus and globus pallidus onunenhanced T1-weighted MR images: relationship with increasing cumulativedose of a gadolinium-based contrast material / T. Kanda, K. Ishii, H. Kawaguchi[et al] // Radiology – 2014. – V.270 (3). – P. 834-841.74.Kanda T. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic GadoliniumChelate Administration / T.
Kanda, M. Osawa, H. Oba [et al] // Radiology. – 2015.– V.275 (3). – P. 803-809.75.Kang Y. Intrahepatic mass-forming cholangiocarcinoma: enhancementpatterns on gadoxeticacid-enhanced MR images / Y. Kang, J.M. Lee, S.H. Kim [etal] // Radiology. – 2012. – V.264(3). – P.751-760.13176.Kenis C. Diagnosis of liver metastases: can diffusion-weighted imaging(DWI) be used as a stand alone sequence? / C. Kenis, F. Deckers, B.
De Foer [etal] // Eur. J. Radiol. – 2012. – V. 81(5). – P.1016-1023.77.Kim H.D. Evaluation of early-stage hepatocellular carcinoma by magneticresonance imaging with gadoxetic acid detects additional lesions and increasesoverall survival / H.D. Kim, Y.S. Lim, S. Han [et al] // J. Gastroenterol. – 2015. –V. 148 (7). – P.
1371-1382.78.Kim K.A. Prediction of microvascular invasion of hepatocellular carcinoma:usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhancedhepatobiliary phase images / K.A. Kim, M.J. Kim, H.M. Jeon [et al] // J. Magn.Reson. Imaging. – 2012. – V. 35(3). – P. 629-634.79.Kim S.Y. Comparison of hepatocellular carcinoma conspicuity onhepatobiliary phase images with gadoxetate disodium vs.
delayed phase imageswith extracellular contrast agent / S.Y. Kim, E.H. Wu, S.H. Park [et al] // Abdom.Radiol. (NY). – 2016. – V. 41(8). – P.1522-1531.80.Kim T. Diffusion-weighted single-shot echoplanar MR imaging for liverdisease / T. Kim, T. Murakami, S. Takahashi [et al] // Am. J. Roentgenol. – 1999. –V. 173(2). – P. 393-398.81.Kim Y.K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
